Literature DB >> 21053305

Measuring mast cell mediator release.

Hye Sun Kuehn1, Madeleine Radinger, Alasdair M Gilfillan.   

Abstract

Mediators released from activated mast cells are responsible for the allergic inflammatory reactions associated with disease states such as anaphylaxis and atopy. These mediators are released as a consequence of immediate degranulation and phospholipid metabolism upon mast cell activation, followed by delayed cytokine gene expression. Thus, techniques that monitor indices of these events in mast cell culture systems, in association with biochemical analysis of parameters of cell signaling, are critical to our understanding of the molecular mechanisms regulating mast cell-mediated disease. Furthermore, these systems can be adapted for high-throughput screens to identify potential inhibitors of mast cell activation that may provide potential leads for novel therapies for these diseases. In this unit, we describe approaches that can be readily used or adapted to a variety of rodent and human mast cell culture systems for the determination of degranulation, phospholipid-derived inflammatory mediator production, and cytokine generation.
© 2010 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21053305      PMCID: PMC2982193          DOI: 10.1002/0471142735.im0738s91

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  10 in total

Review 1.  Mast-cell responses to pathogens.

Authors:  Jean S Marshall
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

Review 2.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

Review 3.  Integrated signalling pathways for mast-cell activation.

Authors:  Alasdair M Gilfillan; Christine Tkaczyk
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

4.  Assays for regulated exocytosis of mast cell granules.

Authors:  Ulrich Blank; Juan Rivera
Journal:  Curr Protoc Cell Biol       Date:  2006-10

Review 5.  Mast cells.

Authors:  D D Metcalfe; D Baram; Y A Mekori
Journal:  Physiol Rev       Date:  1997-10       Impact factor: 37.312

6.  FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells.

Authors:  Huihong Qiao; Marcus V Andrade; Felipe A Lisboa; Katrina Morgan; Michael A Beaven
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

Review 7.  Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation.

Authors:  Joshua A Boyce
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

Review 8.  The mast cell and allergic diseases: role in pathogenesis and implications for therapy.

Authors:  J M Brown; T M Wilson; D D Metcalfe
Journal:  Clin Exp Allergy       Date:  2007-11-21       Impact factor: 5.018

9.  Measurement of prostaglandins and other eicosanoids.

Authors:  W F Stenson
Journal:  Curr Protoc Immunol       Date:  2001-05

10.  Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells.

Authors:  Thomas R Hundley; Alasdair M Gilfillan; Christine Tkaczyk; Marcus V Andrade; Dean D Metcalfe; Michael A Beaven
Journal:  Blood       Date:  2004-06-24       Impact factor: 22.113

  10 in total
  43 in total

1.  Dual action of neurokinin-1 antagonists on Mas-related GPCRs.

Authors:  Ehsan Azimi; Vemuri B Reddy; Kai-Ting C Shade; Robert M Anthony; Sebastien Talbot; Paula Juliana Seadi Pereira; Ethan A Lerner
Journal:  JCI Insight       Date:  2016-10-06

2.  Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.

Authors:  John T Norton; Tomoko Hayashi; Brian Crain; John S Cho; Lloyd S Miller; Maripat Corr; Dennis A Carson
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

3.  A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.

Authors:  Melody C Carter; Avanti Desai; Hirsh D Komarow; Yun Bai; Sarah T Clayton; Alicia S Clark; Karina N Ruiz-Esteves; Lauren M Long; Daly Cantave; Todd M Wilson; Linda M Scott; Olga Simakova; Mi-Yeon Jung; Jamie Hahn; Irina Maric; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2017-06-16       Impact factor: 10.793

4.  Exon skipping of FcεRIβ eliminates expression of the high-affinity IgE receptor in mast cells with therapeutic potential for allergy.

Authors:  Glenn Cruse; Yuzhi Yin; Tomoki Fukuyama; Avanti Desai; Greer K Arthur; Wolfgang Bäumer; Michael A Beaven; Dean D Metcalfe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

5.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

6.  The FcεRIβ homologue, MS4A4A, promotes FcεRI signal transduction and store-operated Ca2+ entry in human mast cells.

Authors:  Greer K Arthur; Lauren C Ehrhardt-Humbert; Douglas B Snider; Corey Jania; Stephen L Tilley; Dean D Metcalfe; Glenn Cruse
Journal:  Cell Signal       Date:  2020-03-30       Impact factor: 4.315

7.  IL-33 induces a hyporesponsive phenotype in human and mouse mast cells.

Authors:  Mi-Yeon Jung; Daniel Smrž; Avanti Desai; Geethani Bandara; Tomonobu Ito; Shoko Iwaki; Jeong-Han Kang; Marcus V Andrade; Susana C Hilderbrand; Jared M Brown; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

8.  Prevention of F-actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells.

Authors:  Daniel Smrž; Geethani Bandara; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Eur J Immunol       Date:  2013-06-04       Impact factor: 5.532

9.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

10.  Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined.

Authors:  Sandra E Dillahunt; Jennifer L Sargent; Ryo Suzuki; Richard L Proia; Alasdair Gilfillan; Juan Rivera; Ana Olivera
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.